Retrovirus Testing

Detection methods

Method Principles

Regulatory Focus

Cocultivation Assay

This method utilizes sensitive indicator cells to capture infectious viral particles and determines the contamination status by observing phenomena such as cytopathic effects, focal formation, or specific antigen expression. It can demonstrate the presence of infectious retroviral particles.

• Mandatory testing targets: EOPC cells or production-limited passage cells.

• Core testing procedure: A two-stage co-culture system (viral amplification phase and activity indicator phase) must be used.

• Sensitive cell requirements: Depending on the species and origin of the cells being tested, different or multiple sensitive cell lines must be used for retroviral infectivity assays.

• Culture passaging requirements: The co-culture system must be passaged at least 5 times (usually more) to ensure adequate amplification of the potential virus.

Transmission Electron Microscopy

This method utilizes high-resolution transmission electron microscopy to directly observe the morphology and structure of viral particles (such as the typical icosahedral envelope structure and nucleocapsid morphology), enabling visual identification and quantitative analysis. It can detect known and unknown viral particles, including non-replicating particles or those not captured by infectivity assays.

• Mandatory testing targets: EOPC cells or production-limited passage cells.

• Core requirement: The type and quantity of retroviral particles must be identified.

• Sample requirements: Ultrathin sectioning is required, typically requiring systematic observation of at least 200 cells.

• Special provisions (Chinese Pharmacopoeia 2025): For certain rodent cells (e.g., CHO, BHK-21) or insect cells, the amount of viral particles in the harvest fluid and their infectivity should also be determined.

Reverse Transcriptase Assay

Based on the characteristic of reverse transcriptase catalyzing the synthesis of DNA from an RNA template, the presence of retroviruses can be indirectly determined by detecting the radioactive or fluorescent signals of the reaction products to quantify enzyme activity. This method is independent of viral infectivity and can broadly screen for viral particles with enzymatic activity.

• Exemption Explanation: Both ICH Q5A(R2) and the Chinese Pharmacopoeia (2025 Edition) clearly state that this test is not required for cells known to produce retroviruses (such as certain rodent, insect, and avian cells).

• Alternative Requirements: In cases of exemption, a more comprehensive test for virus particle type, quantity, and infectivity must be performed.

PCR or other specific in vitro methods

Based on the species specificity of cells, when the reverse transcriptase activity results are unclear or cannot be measured, species-specific retrovirus detection methods can be used, such as retrovirus PCR, immunofluorescence, ELISA, etc. Quantitative PCR of retroviruses can also be used for the quantification of retrovirus particles.

• Primary Positioning: Typically used as an important supplement to the core methods mentioned above and a tool for confirming specificity.

• Application Scenarios: Commonly used for highly sensitive detection and quantification of specific known viruses (e.g., qPCR), or to provide molecular-level evidence when infectivity/electron microscopy results are questionable.

• Regulatory Basis: Its application requires thorough validation and must comply with the relevant guidelines for the validation of specific detection methods in the target market (e.g., the Chinese Pharmacopoeia (2025 Edition)).

Professional services

Comprehensive protection for you

Global Compliance Approach

Our testing methods are deeply integrated with the core requirements of ICH Q5A(R2), Chinese Pharmacopoeia (2025), USP, and EP, providing a one-stop service covering infectiousness testing, transmission electron microscopy (TEM), and reverse transcriptase activity detection, efficiently supporting simultaneous application in multiple regions including China, the US, and Europe.

Broad-spectrum detection capability

We have a variety of sensitive cell lines and mature methods for different risk scenarios, which can effectively detect target pathogens including murine retroviruses, tropism retroviruses, and insect retroviruses, ensuring the broad spectrum and specificity of detection.

Own electron microscopy platform

We have our own high-resolution transmission electron microscope and a senior professional technical team to achieve closed-loop quality control throughout the entire process from sample preparation to data output. We can also provide rapid quantitative services for raw materials (UPB) to accurately support downstream virus clearance verification.

Comprehensive method validation

All methods are performed under GMP/GLP standards, strictly adhering to the Chinese Pharmacopoeia (2025 Edition) and ICH Q2(R2) for comprehensive validation of specificity, detection limits, etc. We provide full-cycle project management from protocol design to application support, ensuring data compliance and reliability.

Data integrity protection

From sample receipt and experiment execution to report issuance, we have established a complete quality system that complies with GMP and ALCOA+ principles. Through professional multi-level data review and a robust deviation control (CAPA) mechanism, we fundamentally ensure high-quality and auditable delivery for every project.